Riggs Josh 4
4 · Oncocyte Corp · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2023-01-17+257,485→ 257,485 totalExercise: $0.46Exp: 2033-01-17→ Common Stock (257,485 underlying)
Footnotes (1)
- [F1]The options will become exercisable in three equal installments on each of January 17, 2024, January 17, 2025 and January 17, 2026, subject to continuous service through the applicable vesting date.